Oral Cancer Histopathology Explained: Margins, ENE, PNI, LVI and Neck Nodes After Surgery

What do clear, close and positive margins mean?

Margins describe whether cancer cells are seen at or near the edge of the removed tissue. A clear margin usually means no cancer cells are seen for adequate distance (typically 5 mm or more) from the cut edge.

A close margin means the cancer is near the edge (often between 1 mm and 5 mm). A positive margin means cancer cells are present at the cut edge. Positive or very close margins may increase recurrence risk and often require careful discussion about further surgical re-resection, radiation therapy or chemoradiation.

Why neck lymph nodes and extranodal extension matter

Neck nodes are lymph nodes removed from the neck during neck dissection. The report may mention how many were removed and how many contained cancer (e.g., 2/25 nodes positive). The number of involved nodes, their size, side of neck and other features influence the need for radiation and the areas to be treated.

Extranodal extension, often written as ENE (or ECS, extracapsular spread), means cancer has spread outside the capsule of a lymph node into surrounding fatty tissue. ENE is an important high-risk feature. Its presence can change treatment from radiation alone to chemoradiation, unless limited by overall fitness and other factors.

ENE matters because it suggests a higher risk of microscopic cancer cells remaining in the neck or nearby tissues. This risk cannot usually be seen with the naked eye after surgery. That is why chemoradiotherapy may be recommended after surgery when ENE is present.

What do PNI and LVI mean?

The presence of ENE does not mean treatment has failed. It means the post-operative treatment plan must be intensified. The oncology team may discuss radiation dose, treatment volume, whether chemotherapy can be safely added, wound healing, dental preparation, nutrition and timing from surgery.

Not every patient with ENE is treated identically. Age, kidney function, hearing, nutrition, general health, other pathology features, wound status and patient preference all matter. If chemotherapy is considered too risky, radiation alone or modified approaches may be discussed depending on the case.

Families sometimes ask why ENE was not known before surgery. The reason is that ENE is often a microscopic finding. Scans may suggest suspicious lymph nodes, but the exact capsular spread may only be confirmed after the lymph node is removed during surgery and examined in the laboratory.

How the pathology report changes radiation or chemoradiation decisions

Perineural invasion, or PNI, means cancer cells are seen tracking along nerves. Lymphovascular invasion, or LVI, means cancer cells are seen in lymphatic or blood-vessel spaces. These features may increase the risk of local, regional or distant recurrence and can influence adjuvant treatment decisions.

The report may also describe tumour size, depth of invasion (DOI), histological grade, bone involvement, skin involvement and pathological stage. No single line should be interpreted in isolation. The whole report must be read together with the operation note, imaging, patient condition and multidisciplinary advice.

Turn general information into a useful medical discussion

Start by writing down the parts of this guide that appear relevant and the parts that do not match what you have been told. Do not use an online article to change medicines, skip an investigation or delay treatment on your own. Instead, ask the treating team to connect the general principle to your diagnosis, stage and treatment intent. If a term in the report is unclear, request the exact wording and an explanation in language you can repeat back.

Bring the pathology report, the actual CT, MRI or PET images as well as their written reports, operation notes, previous treatment summaries, current medicines and recent blood tests. Previous radiation needs special attention: a safe re-irradiation opinion may require the original digital plan, dose distribution and structure set, not only a discharge card. Sending records before the visit can leave more appointment time for decisions and questions.

It can help to create a one-page timeline with the biopsy date, major scan dates, surgery, medicine cycles and the recommendation currently being considered. Add your most important priorities, such as preserving an organ, reducing travel, maintaining work, fertility, urinary or bowel function, or understanding the chance of needing additional treatment. These priorities do not replace cancer-control considerations, but they help the doctor compare medically reasonable options in a way that fits your life.

Finally, distinguish urgent symptoms from decision questions. New weakness, severe bleeding, breathing difficulty, uncontrolled pain, confusion, fever or inability to drink may need prompt hospital assessment rather than a routine appointment or WhatsApp exchange. For a non-urgent decision, leave the consultation with a written next step, the expected time frame and a contact point for questions that arise after you review the discussion with your family.

Look beyond reassuring words and technology labels

Cancer information often uses words such as precision, advanced, targeted or minimally invasive. These terms can describe useful capabilities, but they do not prove that a treatment is appropriate or superior for one person. Ask what clinical problem a technique solves, what evidence supports it for your diagnosis and stage, and whether a simpler or different option could achieve the same goal. A machine brand, session count or dramatic dose image should never replace an explanation of treatment intent and expected benefit.

Useful comparisons include the complete pathway: preparation, other treatments, likely side effects, recovery, follow-up and the chance that additional treatment will be needed. Ask the clinician to separate common effects from rare serious risks and to state where evidence is strong, uncertain or based mainly on patient selection. If percentages are quoted, ask which group they came from and whether that group resembles your situation.

High-quality care also includes processes patients may not see: pathology and imaging review, contouring, peer discussion, physics quality assurance, image guidance, symptom support and a plan for anatomical change. These processes are less marketable than a machine name but often determine whether technology is used well. The best consultation should make the reasoning clearer, not simply make the treatment sound impressive.